FUNCTIONAL ASPECTS OF THE MULTICATALYTIC PROTEINASE COMP
FUNCTIONAL ASPECTS OF THE MULTICATALYTIC PROTEINASE COMP
批准号:
3083260
负责人:
CHRISTOPHER P CARDOZO
金额:
$8.67万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-07-01 至 1996-06-30
关键词:
SDS polyacrylamide gel electrophoresis acidity /alkalinity active sites animal tissue calcium cell growth regulation endopeptidases enzyme activity enzyme structure enzyme substrate analog high performance liquid chromatography magnesium peptide chemical synthesis polyamines protease inhibitor protein degradation protein sequence protein structure function serine proteinases sodium synthetic peptide tissue /cell culture
中文摘要
多催化酶复合体(MPC),也被称为
蛋白酶体,是一个高分子质量(约700 kDa)
由28至32个低分子质量亚基组成的胞内颗粒
(22至34 kDa),其中13个不相同。货币政策委员会的重要性
对于基本细胞功能的研究表明它是
在所有真核细胞中都存在,它在
进化,它参与了抗原的处理,它
构成泛素依赖途径的“蛋白分解核心”
对于细胞内的蛋白水解酶来说,它是细胞不可缺少的
生存和繁殖。MPC表达的变化有
与恶性肿瘤的病理生理学有关,以及
在患者的血清中发现了抗MPC的自身抗体
系统性红斑狼疮。货币政策委员会展示了三个不同的
蛋白水解性裂解羧基侧肽的活性
碱性、酸性和疏水性氨基酸残基,均对
一般丝氨酸3,4-二氯异香豆素(DCI)的灭活
蛋白酶抑制剂。我们最近发现了第四种耐DCI病毒
裂解支链羧基一侧的肽键的成分
链氨基酸,并构成降解的一个主要因素
蛋白质和天然多肽。这个实验室的主要目标是
确定MPC的哪些亚基和多少亚基是
蛋白水解性,鉴定其特异性和蛋白水解性
机制,以检查调节蛋白分解活性的因素
并合成可用作探针的特定抑制剂
该复合体在细胞功能中的作用的研究。的目标是
这项建议是:1)评估特异度和调节
第四,抗DCI组分的活性,2)以确定是否
最近发现的脯氨酸氨基肽酶活性表达为
MPG的一种新成分,如果是这样的话,研究其性质
和专一性,3)确定最近发现的一个脯氨基-
内肽酶活性是由一个独特的成分引起的,如果是这样的话
检查其属性和特异性,4)调查
一组多肽的结构要求和动力学
激活MPC,5)检查完好细胞中MPC的功能
通过研究特异性抑制剂对细胞内蛋白的影响
对降解和细胞增殖的影响。
英文摘要
The multicatalytic proteinase complex (MPC), also referred to as the
proteasome, is a high molecular mass (approximately 700 kDa)
intracellular particle composed of 28 to 32 low molecular mass subunits
(22 to 34 kDa) of which 13 are nonidentical. The importance of the MPC
for fundamental cell functions is indicated by the finding that it is
present in all eukaryotic cells, that it is highly conserved in
evolution, that it is involved in antigen processing, that it
constitutes the 'proteolytic core' of the ubiquitin-dependent pathway
for intracellular proteolysls and that it is indispensable for cell
survival and proliferation. Changes in the expression of the MPC have
been implicated in the pathophysiology of malignancies, and
autoantibodies against the MPC have been found in serum of patients
with systemic lupus erythematosus. The MPC exhibits three distinct
proteolytic activities cleaving peptide bonds on the carboxyl side of
basic, acid and hydrophobic amino acid residues, all sensitive to
inactivation by 3,4-dichloroisocoumarin (DCI), a general serine
protease inhibitor. We have recently identified a fourth, DCI resistant
component that cleaves peptide bonds on the carboxyl side of branched
chain amino acids, and constitutes a major factor in the degradation of
proteins and natural peptides. Major goals of this laboratory are to
determine which and how many of the subunits of the MPC are
proteolytically active, to identify their specificity and proteolytic
mechanism, to examine factors that regulate the proteolytic activity
and to synthesize specific inhibitors that could be used as probes in
studies on the role of the complex in cellular functions. The aims of
this proposal are: 1) to evaluate the specificity and regulation of
activity of the fourth, DCI resistant component, 2) to determine if a
recently identified prolyl aminopeptidase-like activity is expressed by
a novel component of the MPG, and if so to investigate its properties
and specificity, 3) to determine if a recently identified prolyl-
endopeptidase-like activity is due to a unique component, and if so to
examine its properties and specificity, 4) to investigate the
structural requirements and kinetics of a group of peptides that
activate the MPC, 5) to examine the function of the MPC in intact cells
by studying the effect of specific inhibitors on intracellular protein
degradation and on cell proliferation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ShEEP Request for a Multimodal Plate Reader
-
批准号:10738976
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
-
批准号:10418624
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
-
批准号:10664874
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
ShEEP-IC: Jess Simple Western System
-
批准号:10176059
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
ShEEP Request for A Metabolic and Behavioral Phenotyping System
-
批准号:9795306
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
[ShEEP/LAMb] Request for a Seahorse Extracellular Flux Analyzer
-
批准号:9209599
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
-
批准号:8202501
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
-
批准号:8424827
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
-
批准号:8840070
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Attenuation of denervation atrophy by nandrolone: molecular mechanisms
-
批准号:7750432
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Attenuation of denervation atrophy by nandrolone: molecular mechanisms
-
批准号:8837614
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
FUNCTIONAL ASPECTS OF MULTICATALYTIC PROTEINASE
-
批准号:2210646
-
项目类别:
-
资助金额:$8.74万
-
财政年份:1993
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
FUNCTIONAL ASPECTS OF MULTICATALYTIC PROTEINASE
-
批准号:2210645
-
项目类别:
-
资助金额:$8.73万
-
财政年份:1993
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
CYSTEINE PROTEASE-CYSTATIN C BALANCE IN THE LUNG
-
批准号:3051498
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1992
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
CYSTEINE PROTEASE-CYSTATIN C BALANCE IN THE LUNG
-
批准号:3051497
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1991
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
CYSTEINE PROTEASE-CYSTATIN C BALANCE IN THE LUNG
-
批准号:3051496
-
项目类别:
-
资助金额:$3.45万
-
财政年份:1990
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位: